Silo Pharma Inc. (NASDAQ: SILO)
$1.3500
+0.1000 ( +8.00% ) 501.1K
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Market Data
Open
$1.3500
Previous close
$1.2500
Volume
501.1K
Market cap
$6.14M
Day range
$1.1850 - $1.4400
52 week range
$0.8410 - $4.5000
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Aug 31, 2023 |
10-q | Quarterly Reports | 60 | Aug 11, 2023 |